Polar Capital Holdings’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-140,536
Closed -$2.69M 303
2025
Q1
$2.69M Sell
140,536
-2,364
-2% -$69.2K 0.02% 251
2024
Q4
$5.15M Sell
142,900
-11,052
-7% -$374K 0.03% 248
2024
Q3
$6.53M Buy
+153,952
New +$6.53M 0.03% 229
2023
Q4
Sell
-11,210
Closed -$233K 310
2023
Q3
$233K Hold
11,210
﹤0.01% 275
2023
Q2
$275K Hold
11,210
﹤0.01% 281
2023
Q1
$455K Sell
11,210
-9,296
-45% -$385K ﹤0.01% 284
2022
Q4
$922K Hold
20,506
0.01% 276
2022
Q3
$981 Buy
20,506
+1,833
+10% +$100K 0.01% 299
2022
Q2
$1.1K Buy
18,673
+3,500
+23% +$287K 0.01% 298
2022
Q1
$1.76K Hold
15,173
0.01% 308
2021
Q4
$2.28K Hold
15,173
0.01% 293
2021
Q3
$1.81K Sell
15,173
-3,521
-19% -$388K 0.01% 305
2021
Q2
$1.82K Buy
18,694
+2,450
+15% +$218K 0.01% 307
2021
Q1
$1.43M Buy
16,244
+5,575
+52% +$518K 0.01% 284
2020
Q4
$1.02M Buy
+10,669
New +$1.1M 0.01% 290

Other funds holding TNDM

Polar Capital Holdings's TNDM Position: Q2 2025 in Review

Polar Capital Holdings sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 140,536 shares — an estimated $2.69M sold.

Polar Capital Holdings first reported a position in TNDM in Q4 2020 and held it in 15 quarters. The position peaked at $6.53M in Q3 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Polar Capital Holdings reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Polar Capital Holdings sold 140,536 Tandem Diabetes Care shares in Q2 2025, an estimated $2.69M.
  • Polar Capital Holdings first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 15 quarters.
  • Polar Capital Holdings's Tandem Diabetes Care position peaked at $6.53M in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Polar Capital Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.